We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Illustration

Study Finds New Saliva-Based Antibody Test for SARS-CoV-2 Highly Accurate

A new saliva-based test developed by a team at Johns Hopkins Bloomberg School of Public Health (Baltimore, MD, USA) has been found to accurately detect the presence of antibodies to SARS-CoV-2 from small samples of saliva. More...
16 Nov 2020
Image: Model of C-reactive protein (CRP) (Photo courtesy of Wikimedia Commons)

CRP Tracking Predicts Potential Outcome for Hospitalized COVID-19 Patients

By tracking the increase in circulating levels of the inflammatory biomarker C-reactive protein, doctors are able to predict whether newly hospitalized COVID-19 patients will suffer respiratory deterioration with the possible need for intubation. More...
16 Nov 2020
Illustration

Lung Ultrasound Scan Findings Can Help Identify False-Negative COVID-19 Test Results

A new study has found that the integration of lung ultrasound (LUS) with clinical evaluation is associated with increased sensitivity for the diagnosis of COVID-19 pneumonia, and may facilitate the identification of false negative SARS-CoV-2 RT-PCR results. More...
13 Nov 2020
Illustration

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling

PerkinElmer, Inc.’s (Waltham, MA; USA) SARS-CoV-2 Real-time RT-PCR Assay has received CE-IVD marking for the use of saliva as specimen type and the option to pool up to five specimens collected from individuals suspected of COVID-19 or asymptomatic individuals. More...
13 Nov 2020
Illustration

New COVID-19 Test That Identifies T-Cell Signature Better at Detecting Past Coronavirus Infection

New research shows that the unique properties of T cells could make a test that detects virus-specific T cells in a more effective way to assess SARS-CoV-2 exposure before antibodies arise and after they wane. More...
12 Nov 2020
Illustration

Co-Diagnostics’ CoPrimers Platform Demonstrates Effectiveness in COVID-19 Saliva PCR Tests Without Sample Extraction

A new platform technology has shown to be effective in COVID-19 saliva PCR tests without sample extraction. More...
12 Nov 2020
Image: Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response (Photo courtesy of TScan Therapeutics)

Qiagen and TScan Therapeutics to Jointly Develop T Cell-Based Laboratory Test for COVID-19 Immune Response

 QIAGEN N.V. (Venlo, Netherlands) and TScan Therapeutics (Waltham, MA, USA) have entered into a research license and option agreement to develop T cell-based laboratory tests for detecting prior exposure to the novel coronavirus, SARS-CoV-2, using discoveries from TScan’s high-throughput TCR/Target discovery platform, T-Scan. More...
11 Nov 2020
Gold Member
Turnkey Packaging Solution
HLX
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Newborn Screening Test
NeoMass AAAC 3.0
New
Thyroxine ELISA
T4 ELISA
Copyright © 2000-2024 Globetech Media. All rights reserved.